Annexon, Inc.

NASDAQ:ANNX

Biotechnology

Healthcare
$3.52 -0.71%

-$0.04 today

Market cap
$576.73M
Beta
1.18
P/E (TTM)
-4.8
EPS (TTM)
-$1.01
52W Low $1.85High $7.18

Volume 2.98M

Average 2.56M

ANNX Effect of Forex Changes

Change in reported cash caused by exchange-rate movements on foreign-currency balances.

Annexon, Inc.NASDAQ: ANNX

Effect of Forex Changes · Q1 FY2026 · quarter ended Mar 2026

Effect of forex changes outflow grows to $1K

Q1 FY2026 effect of forex changes was $1K, compared with $0 a year earlier. Trailing-twelve-month effect of forex changes was $3K. Over 3 fiscal years it compounded at +26.0% a year.

Context

  • Effect of forex changes increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly effect of forex changes holds near $1K or moves back toward the trailing-twelve-month quarterly average of $750.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$1K— QoQ
Last fiscal yearDec 2025
$2K+113.3% YoY
LTMMar 2026
$3K+200.0% YoY
Effect of Forex Changes past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year+113.3%——
3-year CAGR+26.0%——
5-year CAGR——
10-year CAGR——

Effect of Forex Changes history

USD · from the cash flow

Latest · FY2025
2K USD
Year-over-year change
+113.3%

Effect of Forex Changes vs competitors

How ANNX compares with its peers on the latest reported figures

  • Peers report in different currencies, so effect of forex changes is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +200.0% is the 3rd highest of 7, against a peer median of +133.8%.
  • Over three fiscal years its annual growth of +26.0% compares with a peer median of +42.7%.
ANNX Competitors
Effect of Forex Changes for ANNX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ABVXAbivax S.A.FY2025€26.29M EUR+1003.9%——
IFRXInflaRx N.V.LTM Mar 2026€7.93M EUR+1284.4%—27025.6%
ACIUAC Immune S.A.LTM Dec 2025CHF 2.62M CHF+58.7%+42.7%73.4%
IMVTImmunovant, Inc.LTM Sep 2026$806K USD+148.0%—11.4%
XNCRXencor, Inc.LTM Jun 2026$103K USD+3.0%—0.1%
ALMSAlumis Inc. Common StockLTM Jun 2026$70K USD+119.6%—0.9%
ANNXAnnexon, Inc.LTM Mar 2026$3K USD+200.0%+26.0%—
ANABAnaptysBio, Inc.LTM Mar 2026$0 USD——0.0%
ACRSAclaris Therapeutics, Inc.LTM Mar 2026$0 USD——0.0%
PRTAProthena Corporation plcLTM Mar 2026$0 USD——0.0%
QTTBQ32 Bio Inc.LTM Mar 2026$0 USD——0.0%
Peer median (excluding ANNX) —+133.8%+42.7%0.1%

Competitors are the stored peer set for ANNX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(130.32M)(141.95M)(134.24M)(138.2M)(206.69M)
Depreciation & Amortization3.41M2.11M2.15M2.15M2.17M
Deferred Income Tax00000
Stock-Based Compensation018.52M18.18M19.43M16.42M
Change in Working Capital3.28M3.74M(5.81M)6.36M4.23M
Accounts Receivables00000
Inventory00000
Accounts Payables3.86M(287K)(2.08M)4.94M4.49M
Other Working Capital(575K)4.03M(3.73M)1.43M(261K)
Other Non-Cash Items17.52M1.28M(1.43M)(7.75M)(2.49M)
Operating Cash Flow(106.11M)(116.31M)(121.14M)(118.01M)(186.36M)
Capital Expenditures(1.65M)(6.53M)(193K)(15K)(137K)
Acquisitions (Net)0(64.97K)000
Purchases of Investments(225.6M)(113.2M)(108.09M)(583.93M)(212.21M)
Sales of Investments139.02M178.17M178.98M365.15M402.4M
Other Investing Activities064.97K000
Investing Cash Flow(88.24M)58.44M70.7M(218.8M)190.05M
Debt Repayment00000
Common Stock Issued1.8M130.48M135.51M161.87M110.47M
Common Stock Repurchased00000
Dividends Paid0000(1.86M)
Other Financing Activities0(7.57M)14K(665K)238K
Financing Cash Flow1.8M122.91M135.52M161.21M108.86M
Effect of Forex Changes(1.17M)1K5K(15K)2K
Net Change in Cash(193.72M)65.04M85.09M(175.61M)112.55M
Free Cash Flow(107.76M)(122.84M)(121.34M)(118.02M)(186.49M)

Annexon, Inc.

NASDAQ:ANNX

Intrinsic Alpha fair value

Locked

Current Price

$3.52

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.